CryoPort (CYRX) has agreed to sell its CRYOPDP unit, a specialty courier focused on clinical trials, biopharma, and cell and gene therapies, to DHL Group, according to a Monday statement from the companies.
No financial terms were disclosed. The companies said they also agreed to form a strategic partnership to strengthen their supply chain services for the global life sciences and healthcare sector.
CryoPort said it also expects the partnership with DHL to support its business in the Asia Pacific and Europe, the Middle East and Africa regions.
The sale and and the partnership remain subject to regulatory approvals, according to the companies.
Price: 6.41, Change: +0.32, Percent Change: +5.25
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。